Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective
- PMID: 1493390
- PMCID: PMC1884109
- DOI: 10.1136/bmj.305.6867.1457
Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective
Abstract
Objective: To assess the potential effects of primary prevention with anticoagulants or aspirin in atrial fibrillation on Swedish population.
Design: Analysis of cost effectiveness based on the following assumptions: about 83,000 people have atrial fibrillation in Sweden, of whom 22,000 would be potential candidates for treatment with anticoagulants and 55,000 for aspirin treatment; the annual 5% stroke rate is reduced by 64% (with anticoagulants) and 25% (with aspirin); incidence of intracranial haemorrhage of 0.3%, 1.3%, or 2.0% per year; direct and indirect costs of a stroke of Kr180,000 and Kr90,000; estimated annual cost of treatment is Kr5030 for anticoagulants and Kr100 for aspirin.
Setting: Total Swedish population.
Main outcome measures: Direct and indirect costs of stroke saved, number of strokes prevented, and cost of preventive treatment.
Results: Depending on the rate of haemorrhagic complications 34 to 83 patients would need to be treated annually with anticoagulants to prevent one stroke; 83 patients would need to be treated with aspirin. Giving anticoagulant treatment only would reduce costs by Kr60 million if the incidence of intracranial haemorrhage were 0.3% but would imply a net expense if the complication rate exceeded 1.3%. The total savings from giving anticoagulant (22,000 patients) and aspirin (55,000 patients) treatment would be Kr175 million per year corresponding to 2 million pounds per million inhabitants each year.
Conclusions: Treatment with anticoagulants and, if contraindications exist, with aspirin is cost effective provided that the risk of serious haemorrhage complications due to anticoagulants is kept low.
Comment in
-
Antithrombotic treatment and atrial fibrillation.BMJ. 1992 Dec 12;305(6867):1445-6. doi: 10.1136/bmj.305.6867.1445. BMJ. 1992. PMID: 1493385 Free PMC article. No abstract available.
Similar articles
-
Cost-effectiveness of apixaban compared with aspirin for stroke prevention in atrial fibrillation among patients unsuitable for warfarin.Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):472-9. doi: 10.1161/CIRCOUTCOMES.112.965251. Epub 2012 Jun 26. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22740012
-
Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.JAMA. 1995 Dec 20;274(23):1839-45. JAMA. 1995. PMID: 7500532
-
Cost-effectiveness of apixaban versus warfarin and aspirin in Sweden for stroke prevention in patients with atrial fibrillation.Thromb Res. 2014 Aug;134(2):278-87. doi: 10.1016/j.thromres.2014.05.027. Epub 2014 May 26. Thromb Res. 2014. PMID: 24935675
-
Antithrombotic therapy in atrial fibrillation.Can Fam Physician. 1996 Jul;42:1341-5. Can Fam Physician. 1996. PMID: 8754703 Free PMC article. Review.
-
Atrial fibrillation and stroke. Three new studies, three remaining questions.Arch Intern Med. 1994 Jul 11;154(13):1443-8. Arch Intern Med. 1994. PMID: 8017999 Review.
Cited by
-
A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management.J Clin Pathol. 2002 Nov;55(11):845-9. doi: 10.1136/jcp.55.11.845. J Clin Pathol. 2002. PMID: 12401823 Free PMC article. Clinical Trial.
-
Evaluation of computerized decision support for oral anticoagulation management based in primary care.Br J Gen Pract. 1996 Sep;46(410):533-5. Br J Gen Pract. 1996. PMID: 8917873 Free PMC article. Clinical Trial.
-
Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.Br J Gen Pract. 1995 Mar;45(392):153-8. Br J Gen Pract. 1995. PMID: 7772394 Free PMC article. Review.
-
Hospital costs associated with atrial fibrillation for patients with ischemic stroke aged 18-64 years in the United States.Stroke. 2015 May;46(5):1314-20. doi: 10.1161/STROKEAHA.114.008563. Epub 2015 Apr 7. Stroke. 2015. PMID: 25851767 Free PMC article.
-
Costs and effectiveness of a nurse specialist anticoagulant service.J Clin Pathol. 1997 Oct;50(10):823-8. doi: 10.1136/jcp.50.10.823. J Clin Pathol. 1997. PMID: 9462263 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical